UnitedHealth Group Inc (NYSE:UNH) insider Larry C. Renfro sold 22,184 shares of the firm’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the transaction, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of UNH stock opened at $226.78 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 1 year low of $162.74 and a 1 year high of $250.79. The company has a market cap of $220,491.67, a P/E ratio of 21.17, a P/E/G ratio of 1.33 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period last year, the company earned $2.11 EPS. The firm’s revenue was up 9.5% compared to the same quarter last year. analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio is presently 28.01%.
Several equities analysts have commented on UNH shares. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a report on Saturday, January 20th. Goldman Sachs started coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a report on Wednesday, January 17th. Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a report on Monday, December 25th. Finally, Piper Jaffray Companies raised their target price on shares of UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a report on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $245.14.
Large investors have recently bought and sold shares of the stock. Aevitas Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $102,000. Exane Derivatives boosted its position in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares during the period. Pathstone Family Office LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $129,000. Trustcore Financial Services LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $133,000. Finally, Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $114,000. Institutional investors and hedge funds own 86.78% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.